Intellia Therapeutics (NTLA) announced that on January 1, 2025, it awarded inducement grants to three new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment. The inducement grants consisted of time-based restricted stock units for 23,155 shares of Intellia’s common stock, with one-third of such RSUs vesting on January 1, 2026, 2027, and 2028. All equity vesting is subject to each employee’s continued service as an employee of, or other service provider to, Intellia through the applicable vesting dates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Cathie Wood’s ARK Investment buys 96.2K shares of Intellia Therapeutics today
- Biotech Alert: Searches spiking for these stocks today
- Intellia announces FDA granted RMAT designation to nexiguran ziclumeran
- Cathie Wood’s ARK Investment buys 223.5K shares of Intellia Therapeutics today
- Intellia Therapeutics Announces Promising CRISPR Therapy Results